Research Study Comparing a New Medicine " Fast-acting Insulin Aspart " to Another Already Available Medicine " NovoRapid " / " NovoLog " in People With Type 2 Diabetes
Conditions:   Diabetes;   Diabetes Mellitus, Type 2 Interventions:   Drug: Faster-acting insulin aspart;   Drug: Insulin aspart;   Drug: Insulin degludec;   Drug: Metformin Sponsor:   Novo Nordisk A/S Not yet recruiting - verified September 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2017 Category: Research Source Type: clinical trials

Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic Pancreas
Condition:   Type 1 Diabetes Mellitus Interventions:   Drug: Humalog;   Drug: Novolog;   Drug: Apidra;   Device: Bionic Pancreas Sponsors:   Massachusetts General Hospital;   Boston University Not yet recruiting - verified August 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2017 Category: Research Source Type: clinical trials